Study #2022-0180
Combination Therapy for Treatment of Sleep Disturbance in Patients with Advanced Cancer
MD Anderson Study Status
Enrolling
Treatment Agent
Melatonin, Methylphenidate
Description
To learn if Cognitive Behavior Therapy (called CBT), combined with either Bright Light Therapy (called BLT), methylphenidate, and/or melatonin, can help improve sleep and other related symptoms such as fatigue, anxiety, and depression in cancer patients. This is an investigational study. In this study, BLT, Methylphenidate and Melatonin will be compared to their placebos.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Sleep, Fatigue, Anxiety, Cancer, Depression
Study phase:
Phase II/III
Physician name:
Sriram Yennu
Department:
Palliative Care & Rehabilitation Medicine
For general questions about clinical trials:
1-877-582-0066
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.